In addition to the differences in the base-line features of tumor vasculature and given that Murine Tek-deltaFc prevents Tie-2 binding with its ligands, diverse tumor angiopoietin blocking should be also considered as a possible explanation for the observed contrasting activity of the inhibitor between the two models. The gene discussed is TEK; the disease is neoplasm.